2006
DOI: 10.1016/j.bbrc.2006.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Changes in S1P1 and S1P2 expression during embryonal development and primitive endoderm differentiation of F9 cells

Abstract: Sphingosine 1-phosphate (S1P) is a ligand for S1P family receptors (S1P 1 -S1P 5 ).Of these receptors, S1P 1 , S1P 2 , and S1P 3 are ubiquitously expressed in adult mice, while S1P 4 and S1P 5 are tissue-specific. However, little is known of their expression during embryonal development. We performed Northern blot analyses in mouse embryonal tissue and found that such expression is developmentally regulated. We also examined the expression of these receptors during primitive endoderm (PrE) differentiation of m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2008
2008
2015
2015

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 36 publications
0
2
0
Order By: Relevance
“…A total of five subtypes of S1PRs (S1PR1-5) have been identified since the first S1PR was discovered by Hla T et al (1990). During the past two decades, S1P and its specific receptors were found to be involved in a wide range of pathophysiological processes (Maceyka et al, 2012) in multiple organ systems that include: the central nervous system, immune system (Soliven et al, 2011; Garris et al, 2014), cardiovascular system (Schmouder et al, 2012), and in embryonic development (Kondo et al, 2014; Hiraga et al, 2006). Further, emerging evidence indicates that S1P/S1PRs play significant roles in the proliferation, progression, survival and therapeutic response to treatment in cancer (Pyne et al, 2010; Kunkel et al, 2013; Pyne et al, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…A total of five subtypes of S1PRs (S1PR1-5) have been identified since the first S1PR was discovered by Hla T et al (1990). During the past two decades, S1P and its specific receptors were found to be involved in a wide range of pathophysiological processes (Maceyka et al, 2012) in multiple organ systems that include: the central nervous system, immune system (Soliven et al, 2011; Garris et al, 2014), cardiovascular system (Schmouder et al, 2012), and in embryonic development (Kondo et al, 2014; Hiraga et al, 2006). Further, emerging evidence indicates that S1P/S1PRs play significant roles in the proliferation, progression, survival and therapeutic response to treatment in cancer (Pyne et al, 2010; Kunkel et al, 2013; Pyne et al, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, enhanced expression of S1P 2 was observed in primary cultured rat hepatocytes depending on cell-cycle transition from G0 to G1, and thus S1P 2 expression was up-regulated during proliferating status (33). F9 embryonic carcinoma cells showed down-regulation for S1P 2 expression when differentiated (35). In addition, myogenic differentiation in C2C12 myoblasts was accompanied with downregulation of S1P 2 (36).…”
Section: +mentioning
confidence: 99%